☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Chronic Autoimmune Diseases
Organon and Samsung Bioepis Launch Hadlima (biosimilar, adalimumab)
July 3, 2023
Sandoz's Hymiroz (adalimumab-adaz) Receives the US FDA Approval for Treatment of Chronic Autoimmune Diseases
October 31, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
